Axsome Therapeutics
Developer of CNS medicines for depression, Alzheimer’s agitation, daytime sleepiness, and migraine.
$199.00
After-hours close−0.07 (−0.04%)
At close$199.07(−3.49%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 96.53%49.68M sharesInsiders 0.29%151.1K sharesOther 3.18%1.63M shares
Shares outstanding 51.46M · Float 43.56M · 84.6% free float
Institutions13F, as of Jun 30, 2026
538 holders · 49.68M shares · 141 new positions · 299 increased · 162 reduced · 43 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 3.10M | 6.03% | −809.1K | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 1.98M | 3.85% | −74.7K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 1.97M | 3.82% | +27.3K | Aug 13, 2026 |
| Invesco Ltd. | 1.67M | 3.25% | +374.0K | Aug 14, 2026 |
| FMR LLC | 1.54M | 2.99% | −27.8K | Aug 13, 2026 |
| Geode Capital Management, LLC | 967.2K | 1.88% | −195.8K | Aug 12, 2026 |
| Morgan Stanley | 804.1K | 1.56% | +327.4K | Aug 13, 2026 |
| State Street Corp | 785.7K | 1.53% | −201.1K | Aug 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Roger Jeffs | director | 58.4K | 0.11% | Jun 11, 2026 |
| Nick Pizzie | officer: Chief Financial Officer | 42.9K | 0.08% | Jun 9, 2026 |
| Mark Coleman | director | 30.4K | 0.06% | Jun 10, 2026 |
| Mark E. Saad | director | 11.4K | 0.02% | Jun 10, 2026 |
| Herriot Tabuteau | director, 10 percent owner, officer: Chief Executive Officer | 7.2K | 0.01% | Aug 7, 2026 |
| Susan Mahony | director | 829 | 0.00% | Jun 10, 2026 |
1 ten-percent owner holds 7.34M shares by Form 4, outside the officers-and-directors figure above · 2 people have not refiled in the last 18 months (10.4K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 6, 2026 | Herriot Tabuteaudirector, 10 percent owner, officer: Chief Executive Officer | Sale | 4,660 | $213.95 | 7,229 |
| Aug 5, 2026 | Herriot Tabuteaudirector, 10 percent owner, officer: Chief Executive Officer | Sale | 45,004 | $212.01 | 7,229 |
| Jul 1, 2026 | Herriot Tabuteaudirector, 10 percent owner, officer: Chief Executive Officer | Sale | 49,666 | $240.25 | 7,229 |
| Jun 11, 2026 | Roger Jeffsdirector | Sale | 286 | $249.12 | 58,367 |
| Jun 10, 2026 | Roger Jeffsdirector | Sale | 286 | $246.18 | 58,653 |
| Jun 10, 2026 | Mark Colemandirector | Sale | 643 | $249.00 | 30,389 |
| Jun 10, 2026 | Susan Mahonydirector | Sale | 300 | $246.18 | 829 |
| Jun 9, 2026 | Susan Mahonydirector | Sale | 300 | $237.21 | 1,129 |
| Jun 9, 2026 | Nick Pizzieofficer: Chief Financial Officer | Sale | 33,000 | $240.09 | 42,867 |
| Jun 9, 2026 | Herriot Tabuteaudirector, 10 percent owner, officer: Chief Executive Officer | Sale | 49,670 | $241.01 | 7,229 |
CongressHouse and Senate disclosures
Not reported.